{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Trial Enrollment For Concussion Treatment Candidate

May 5, 2026Oragenics (NYSE American: OGEN) announced active enrollment at a second site in its Phase IIa clinical trial evaluating ONP-002 for concussion and mild traumatic brain injury, with four patients already dosed at its initial Australian site, as the company progresses toward a planned data readout by year-end 2026. To view the full press release, visit https://ibn.


InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Provides Update On HEAL Access Commercial Progress Ahead Of Proposed Acquisition

May 5, 2026AI Maverick Intel (OTC: AIMV) provided an update on HEAL Access Canada Inc. in connection with its previously announced LOI to acquire the company, noting more than 10 live implementations, 13 signed enterprise agreements, and a platform supporting approximately 79 clinicians and over 118,000 patients across multiple healthcare segments in North America and Europe.


AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured In AINewsWire Editorial On Service Robotics Growth

May 5, 2026Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an AINewsWire editorial highlighting accelerating global demand for service robotics, with the company positioning itself for growth through scalable infrastructure, real-world deployment and strategic partnerships within the expanding AI-driven robotics market. To view the full press release, visit https://ibn.


TechMediaBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Selected for Sohn Investment Conference Emerging Company Pavilion

May 4, 2026SKYX Platforms (NASDAQ: SKYX) announced it has been selected to participate in the inaugural Emerging Company Pavilion at the Sohn Investment Conference 2026, taking place May 12, 2026, at Jazz at Lincoln Center in New York City. The company said it was chosen as one of only eight emerging companies to gain exposure to a targeted group of institutional investors, reflecting its growth profile, market positioning and alignment with investor demand.